Hudson Canyon Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Buy |
9,730
+180
| +2% | +$33.4K | 1.12% | 48 |
|
|
2025
Q1 | $2M | Sell |
9,550
-250
| -3% | -$52.4K | 1.41% | 34 |
|
|
2024
Q4 | $1.74M | Buy |
9,800
+1,150
| +13% | +$204K | 1.14% | 42 |
|
|
2024
Q3 | $1.71M | Buy |
+8,650
| New | +$1.71M | 1.1% | 48 |
|
|
2023
Q2 | – | Sell |
-11,089
| Closed | -$1.77M | – | 56 |
|
|
2023
Q1 | $1.77M | Sell |
11,089
-668
| -6% | -$106K | 1.48% | 35 |
|
|
2022
Q4 | $1.9M | Sell |
11,757
-258
| -2% | -$41.7K | 1.75% | 21 |
|
|
2022
Q3 | $1.61M | Hold |
12,015
| – | – | 1.6% | 25 |
|
|
2022
Q2 | $1.84M | Buy |
12,015
+1,715
| +17% | +$263K | 1.77% | 18 |
|
|
2022
Q1 | $1.67M | Buy |
+10,300
| New | +$1.67M | 1.32% | 44 |
|